mRNA COVID-19 vaccine is well tolerated in patients with cutaneous and systemic mastocytosis with mast cell activation symptoms and anaphylaxis.

Título

mRNA COVID-19 vaccine is well tolerated in patients with cutaneous and systemic mastocytosis with mast cell activation symptoms and anaphylaxis.

Autor

Tiago Azenha Rama, André Moreira, Mariana Castells

Fecha

2021

Identificador

10.1016/j.jaci.2021.01.004

Fuente

The Journal of allergy and clinical immunology

Archivos

https://socictopen.socict.org/files/to_import/pdfs/399b571d5e2f2fe7f9f9fc471c955b03.pdf

Colección

Coronavirus

Citación

Tiago Azenha Rama, André Moreira, Mariana Castells, “mRNA COVID-19 vaccine is well tolerated in patients with cutaneous and systemic mastocytosis with mast cell activation symptoms and anaphylaxis.,” SOCICT Open, consulta 24 de abril de 2026, https://socictopen.socict.org/items/show/8564.

Formatos de Salida

Position: 4945 (35 views)